Telcon Inc (200230) - Total Assets

Latest as of September 2025: ₩156.55 Billion KRW ≈ $106.09 Million USD

Based on the latest financial reports, Telcon Inc (200230) holds total assets worth ₩156.55 Billion KRW (≈ $106.09 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 200230 net assets for net asset value and shareholders' equity analysis.

Telcon Inc - Total Assets Trend (2013–2024)

This chart illustrates how Telcon Inc's total assets have evolved over time, based on quarterly financial data.

Telcon Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Telcon Inc's total assets of ₩156.55 Billion consist of 16.9% current assets and 83.1% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 2.2%
Accounts Receivable ₩8.75 Billion 5.7%
Inventory ₩4.96 Billion 3.2%
Property, Plant & Equipment ₩0.00 0.0%
Intangible Assets ₩18.74 Billion 12.2%
Goodwill ₩0.00 0.0%

Asset Composition Trend (2013–2024)

This chart illustrates how Telcon Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Telcon Inc.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Telcon Inc's current assets represent 16.9% of total assets in 2024, a decrease from 88.1% in 2013.
  • Cash Position: Cash and equivalents constituted 2.2% of total assets in 2024, down from 38.6% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2013.
  • Asset Diversification: The largest asset category is intangible assets at 12.2% of total assets.

Telcon Inc Competitors by Total Assets

Key competitors of Telcon Inc based on total assets are shown below.

Company Country Total Assets
Yabao Pharmaceutical Group Co Ltd
SHG:600351
China CN¥3.34 Billion
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
China CN¥68.33 Billion
Sandoz Group AG
SW:SDZ
Switzerland CHF21.61 Billion
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Sweden Skr67.43 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥14.22 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion

Telcon Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.00 0.31 0.44
Quick Ratio 0.89 0.23 0.39
Cash Ratio 0.00 0.11 0.00
Working Capital ₩-113.23 Million ₩-38.92 Billion ₩-50.77 Billion

Telcon Inc - Advanced Valuation Insights

This section examines the relationship between Telcon Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.57
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 9.4%
Total Assets ₩153.59 Billion
Market Capitalization $29.07 Million USD

Valuation Analysis

Below Book Valuation: The market values Telcon Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Telcon Inc's assets grew by 9.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Telcon Inc (2013–2024)

The table below shows the annual total assets of Telcon Inc from 2013 to 2024.

Year Total Assets Change
2024-12-31 ₩153.59 Billion
≈ $104.08 Million
+9.38%
2023-12-31 ₩140.41 Billion
≈ $95.16 Million
+17.74%
2022-12-31 ₩119.25 Billion
≈ $80.82 Million
-29.03%
2021-12-31 ₩168.03 Billion
≈ $113.87 Million
-9.20%
2020-12-31 ₩185.05 Billion
≈ $125.41 Million
+40.57%
2019-12-31 ₩131.65 Billion
≈ $89.22 Million
-27.58%
2018-12-31 ₩181.79 Billion
≈ $123.20 Million
-13.28%
2017-12-31 ₩209.64 Billion
≈ $142.07 Million
+68.37%
2016-12-31 ₩124.51 Billion
≈ $84.38 Million
+158.57%
2015-12-31 ₩48.15 Billion
≈ $32.63 Million
+0.83%
2014-12-31 ₩47.76 Billion
≈ $32.37 Million
+48.34%
2013-12-31 ₩32.20 Billion
≈ $21.82 Million
--

About Telcon Inc

KQ:200230 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$29.07 Million
₩42.89 Billion KRW
Market Cap Rank
#23806 Global
#1719 in Korea
Share Price
₩626.00
Change (1 day)
-0.32%
52-Week Range
₩618.00 - ₩10340.00
All Time High
₩18250.00
About

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.